Mortality rates on the liver transplant waiting list are increasing. 1 The shortage of organs
has resulted in higher utilization of extended criteria donors (ECDs), with centers pushing …

Currently, nonalcoholic steatohepatitis (NASH) is the second leading indication for liver
transplantation (LT), behind alcohol‐related liver disease. After transplant, both recurrent …

Extended-criteria donors (ECDs) have an impact on early allograft dysfunction (EAD), biliary
complications, relapse of hepatitis C virus (HCV), and survivals. Early allograft dysfunction …

Ischemia/reperfusion (IR) injury occurs when oxygen is rapidly reintroduced into ischemic
tissue, resulting in cell death and necrotic tissue damage. This is a major concern during …

Donation after cardiac death (DCD) liver transplantation is associated with an increased
frequency of hepato-biliary complications. The implications for renal function have not been …

Given the static number of deceased donors, improvements in donor management and
organ preservation to increase the number and quality of organs transplanted per donor are …

Nonalcoholic fatty liver disease (NAFLD) is the most common etiology of chronic liver
disease in developed countries and is on trajectory to become the leading indication for liver …

Liver allograft steatosis is a significant risk factor for postoperative graft dysfunction and has
been associated with inferior patient and graft survival, particularly in the case of moderate …

Donation after cardiac death liver transplant recipients have an increased frequency of acute
kidney injury (AKI). This suggests that hepatic ischemia‐reperfusion injury may play a critical …

Whether ischemic preconditioning (IP) reduces ischemia/reperfusion (I/R) injury in human
normal and fatty livers remains controversial. We compared two independent groups of liver …